SCLC – The forgotten entity | springermedizin.at

Springer Medizin Österreich

nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.04.2011 | Short Review

SCLC – The forgotten entity

verfasst von: F. Ploner

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Anzeige

Vorheriger Artikel Targeted therapies in advanced non-small cell lung cancer: success or failure?

Nächster Artikel Mitomycin C in combination with vinorelbine or cisplatin and erythropoietin in pretreated patients with in field relapse after radiation therapy of non-small cell lung cancer: a phase II trial of the AIO

Titel: SCLC – The forgotten entity
verfasst von: F. Ploner
Publikationsdatum: 01.04.2011
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 1/2011
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-011-0240-0

Weitere Artikel der Ausgabe 1/2011

Targeted therapies in advanced non-small cell lung cancer: success or failure?

Short Review

Maintenance therapy for patients with advanced non-small cell lung cancer: Who to treat and how to treat?

Review

Maintenance therapy for patients with advanced non-small cell lung cancer: fact or myth?

Editorial

STAT signalling in malignant mesothelioma: Is there a regulatory effect of microRNAs?

Original report

Adjuvant chemotherapy in stage IB NSCLC: implication of the new TNM staging system

Short review

Mitomycin C in combination with vinorelbine or cisplatin and erythropoietin in pretreated patients with in field relapse after radiation therapy of non-small cell lung cancer: a phase II trial of the AIO

Original report